to-BBB is a clinical stage biotechnology company developing novel treatments for devastating brain disorders, such as brain cancer and neuroinflammatory diseases. The Company combines existing drugs with to-BBB’s proprietary G-Technology® for enhanced drug delivery across the blood-brain barrier.
Meet us at
European Symposium on Controlled Drug Delivery
» 16 April 2014
World Orphan Drug Congress - Washington
» 23 April 2014
Translational CNS Summit - Boston
» 29 April 2014